Quest Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DGX and other ETFs, options, and stocks.

About DGX

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. 

CEO
James E. Davis
CEOJames E. Davis
Employees
57,000
Employees57,000
Headquarters
Secaucus, New Jersey
HeadquartersSecaucus, New Jersey
Founded
1967
Founded1967
Employees
57,000
Employees57,000

DGX Key Statistics

Market cap
26.92B
Market cap26.92B
Price-Earnings ratio
25.92
Price-Earnings ratio25.92
Dividend yield
1.36%
Dividend yield1.36%
Average volume
809.71K
Average volume809.71K
High today
$245.93
High today$245.93
Low today
$241.39
Low today$241.39
Open price
$242.62
Open price$242.62
Volume
802.58K
Volume802.58K
52 Week high
$246.00
52 Week high$246.00
52 Week low
$171.18
52 Week low$171.18

Stock Snapshot

Quest Diagnostics(DGX) stock is priced at $243.87, giving the company a market capitalization of 26.92B. It carries a P/E multiple of 25.92 and pays a dividend yield of 1.36%.

On 2026-08-24, Quest Diagnostics(DGX) stock traded between a low of $241.39 and a high of $245.93. Shares are currently priced at $243.87, which is +1.0% above the low and -0.8% below the high.

The Quest Diagnostics(DGX)'s current trading volume is 802.58K, compared to an average daily volume of 809.71K.

In the last year, Quest Diagnostics(DGX) shares hit a 52-week high of $246.00 and a 52-week low of $171.18.

In the last year, Quest Diagnostics(DGX) shares hit a 52-week high of $246.00 and a 52-week low of $171.18.

DGX News

TipRanks 16h
Quest Diagnostics to offer FDA-cleared Roche pTau217 blood test

Quest Diagnostics (DGX) announced two new developments for its Quest AD-Detect portfolio of blood-based biomarker tests for Alzheimer’s disease, with the goal o...

MarketWatch 3d
Quest Diagnostics Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

...

Quest Diagnostics Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Simply Wall St 3d
How WHOOP Lab Expansion and Dividend Policy Could Shape Quest Diagnostics' Advanced Diagnostics Narrative

Earlier this month, Quest Diagnostics announced that its Board of Directors declared a quarterly cash dividend of US$0.86 per share, payable on October 21, 2026...

How WHOOP Lab Expansion and Dividend Policy Could Shape Quest Diagnostics' Advanced Diagnostics Narrative

Analyst ratings

50%

of 20 ratings
Buy
45%
Hold
50%
Sell
5%

People also own

Based on the portfolios of people who own DGX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.